Novo Integrated Sciences, Inc.
NVOS
Rank in Stocks
#34466
Novo Integrated Sciences, Inc. (NVOS) delivers a diverse array of primary... Novo Integrated Sciences, Inc. (NVOS) delivers a diverse array of primary healthcare services and related products through its two primary operational segments: Healthcare Services and Product Manufacturing and Development. The company's extensive service portfolio includes various therapeutic approaches such as physiotherapy, chiropractic care, manual manipulation, occupational therapy, and massage therapy. They also offer specialized treatments like acupuncture, functional dry needling, chiropody, and advanced rehabilitation for stroke, traumatic brain injuries, and other neurological conditions. Additionally, NVOS provides kinesiology, vestibular therapy, concussion management, and baseline testing, alongside unique programs like trauma-sensitive yoga and meditation for brain injury recovery and PTSD. Women's pelvic health, sports medicine, assistive device provision, dietetics, holistic nutrition, fall prevention education, sports team conditioning, and private personal training are also part of their offerings. Novo Integrated Sciences, Inc. is dedicated to the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of a wide range of orthopedic, musculoskeletal, sports injury, and neurological conditions. These services are provided across all age demographics, from pediatric and adult patients to geriatric populations. For older adults, the company offers comprehensive eldercare physiotherapy within long-term care homes, retirement communities, and through community-based home care. This includes group exercise classes and fall prevention initiatives, alongside services at outpatient clinics. Similarly, occupational therapy services for the elderly are extended to retirement communities and long-term care facilities. Beyond direct care, the company incorporates medical technology, offering telemedicine consultations and remote patient monitoring. It also actively develops and distributes bespoke health and wellness product solutions. NVOS operates a network of 16 wholly-owned clinics. Established in 2000, the company is headquartered in Bellevue, Washington, and operates as a subsidiary of ALMC-ASAP Holdings, Inc.
Share Price
$0.0008
Last synced: 2026-11-09
Market Cap
$15.78K
Change (1 day)
33.33%
Change (1 year)
-89.33%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Novo Integrated Sciences, Inc. (NVOS)
Category
Healthcare
EPS for Novo Integrated Sciences, Inc. (NVOS)
EPS as of August 2024 TTM: $-0.92
According to Novo Integrated Sciences, Inc.'s latest financial reports, its current EPS (TTM) is $-0.92. At the end of 2024 the company had an EPS of $-0.90, an increase over its 2023 EPS of $-1.30.
EPS history for Novo Integrated Sciences, Inc. from 2004 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.92 | 2.22% |
| 2024 | $-0.90 | -30.77% |
| 2023 | $-1.30 | -88.48% |
| 2022 | $-11.28 | 526.67% |
| 2021 | $-1.80 | -15.49% |
| 2020 | $-2.13 | 1,083.33% |
| 2019 | $-0.18 | -82.35% |
| 2018 | $-1.02 | 142.86% |
| 2017 | $-0.42 | -43.24% |
| 2016 | $-0.74 | -94.43% |
| 2015 | $-13.29 | 108.96% |
| 2014 | $-6.36 | -44.50% |
| 2013 | $-11.46 | -67.48% |
| 2012 | $-35.24 | -58.74% |
| 2011 | $-85.40 | -28.11% |
| 2010 | $-118.79 | -22.69% |
| 2009 | $-153.65 | 47.63% |
| 2008 | $-104.08 | -67.75% |
| 2007 | $-322.75 | 35.42% |
| 2006 | $-238.34 | 29.03% |
| 2005 | $-184.71 | 267.58% |
| 2004 | $-50.25 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $30.27 | -3,390.22% |
US
|
|
| $3.19 | -446.67% |
DE
|
|
| $34.71 | -3,872.83% |
US
|
|
| $1.90 | -306.76% |
SA
|
|
| $0.29 | -131.30% |
CN
|
Questions about Novo Integrated Sciences, Inc.'s earnings per share (EPS)
What is Novo Integrated Sciences, Inc.'s earnings per share (EPS)?
Novo Integrated Sciences, Inc.'s earnings per share (EPS) over the last twelve months is $-0.92, as of Aug 2024.
What was Novo Integrated Sciences, Inc.'s earnings per share (EPS) in 2024?
In 2024, Novo Integrated Sciences, Inc.'s earnings per share (EPS) was $-0.90, compared with $-1.30 in 2023.
How has Novo Integrated Sciences, Inc.'s earnings per share (EPS) changed since 2019?
From 2019 to 2024, Novo Integrated Sciences, Inc.'s earnings per share (EPS) was highest in 2019 ($-0.18) and lowest in 2022 ($-11.28).
How does Novo Integrated Sciences, Inc.'s earnings per share (EPS) compare with similar companies?
Novo Integrated Sciences, Inc.'s earnings per share (EPS) ($-0.92) is lower than that of all 5 similar companies listed above. The highest among them is Tenet Healthcare Corporation, with $34.71.